Skip to content
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • U.S. Psychedelic Policy Reform
    • Worldwide Psychedelic Laws
    • Oregon Psilocybin Services Tracker
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Menu
  • Insights
    • All Insights
    • 2024 Year in Review
    • Pα+ Dashboard
  • Data
    • Psychedelic Company Financing Tracker
    • Psychedelic Drug Development Tracker
    • U.S. Psychedelic Policy Reform
    • Worldwide Psychedelic Laws
    • Oregon Psilocybin Services Tracker
    • Psychedelic Patent Trackers
    • Psychedelic Stocks & Companies
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+ Content
  • Pα+ Sign in
Subscribe
Search
Close this search box.
Read more about the article Kabir Nath: Our Mission, Progress and Future Perspectives

Kabir Nath: Our Mission, Progress and Future Perspectives

  • Post published:January 31, 2023
  • Post category:2022 Year in Review
Read more about the article Late-Stage Psychedelic Trials: A brief review of the two most mature psychedelic drug development programs

Late-Stage Psychedelic Trials: A brief review of the two most mature psychedelic drug development programs

  • Post published:January 30, 2023
  • Post category:2022 Year in Review
Read more about the article Doing Things Differently: Beyond Business as Usual in the Psychedelics Space

Doing Things Differently: Beyond Business as Usual in the Psychedelics Space

  • Post published:January 27, 2023
  • Post category:2022 Year in Review
Read more about the article Adelaide Wilcox King: The Psychedelic Industry as a Catalyst for Reimagining Capitalism and the Purpose-Driven Firm​

Adelaide Wilcox King: The Psychedelic Industry as a Catalyst for Reimagining Capitalism and the Purpose-Driven Firm​

  • Post published:January 27, 2023
  • Post category:2022 Year in Review
Read more about the article Julia Mande: Consider the Conditions: Growing a Psychedelic Ecosystem

Julia Mande: Consider the Conditions: Growing a Psychedelic Ecosystem

  • Post published:January 27, 2023
  • Post category:2022 Year in Review
Read more about the article Adapting to the Squeeze: Spending Trends, Slimming Pipelines, M&A and Partnerships in 2022

Adapting to the Squeeze: Spending Trends, Slimming Pipelines, M&A and Partnerships in 2022

  • Post published:January 26, 2023
  • Post category:2022 Year in Review
Read more about the article Psychedelic Investor Pulse Survey – Q4 2022

Psychedelic Investor Pulse Survey – Q4 2022

  • Post published:January 26, 2023
  • Post category:2022 Year in Review
Read more about the article Panel: Three Psychedelics Companies that Raised in 2022

Panel: Three Psychedelics Companies that Raised in 2022

  • Post published:January 24, 2023
  • Post category:2022 Year in Review
Read more about the article Panel: Psychedelic VCs Reflect on 2022

Panel: Psychedelic VCs Reflect on 2022

  • Post published:January 24, 2023
  • Post category:2022 Year in Review
Read more about the article Psychedelic Funding in 2022

Psychedelic Funding in 2022

  • Post published:January 23, 2023
  • Post category:2022 Year in Review

End of content

No more pages to load

← Newer Posts
Older Posts →

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More